SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Filecoin network achieves staggering economies of scale by allowing anyone worldwide to participate as storage providers. It also makes storage resemble a commodity or utility by decoupling hard-drive space from additional services. On this robust global market the price of storage will be driven by supply and demand, not corporate pricing departments, and miners will compete on factors like reputation for reliability as well as price.

Filecoin

Filecoin is trending as community members discuss its potential within the decentralized storage sector and its competition with Amazon AWS. Speculation around AI and data infrastructure projects utilizing Filecoin's network is fueling interest, with some eyeing a return to all-time highs. Technical analysis and discussions of potential breakouts are also prominent.

Ethereum Classic

Ethereum Classic ($ETC) is trending amid discussions about its potential as a cheaper alternative to Ethereum and renewed interest in Proof-of-Work coins, with some community members anticipating a significant price increase and comparing it to past bull runs. The community is actively debating its performance relative to Ethereum, with some suggesting it's undervalued and poised for a breakout, while others remain skeptical about its long-term potential.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending amid community excitement over its recent price surge and increased staking activity, with many drawing comparisons to ZCash's historical run. The discussion centers around ICP's unique technology, particularly its "full-stack on-chain" model and potential to disrupt traditional internet infrastructure, as well as speculation on short-term price targets.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending as the community anticipates news, especially regarding potential pharmaceutical contracts and the closing of the pension transfer. Discussions center on Kodak's transformation beyond its legacy business, with optimism around its pharmaceutical and battery ventures. Some traders are looking at its potential as the next meme stock.

Concordium is a public, permissionless Layer 1 blockchain designed for businesses that require regulatory compliance without sacrificing privacy. Concordium was among the first to mandate identity verification at the blockchain consensus level while integrating zero-knowledge proofs (ZKPs) for selective disclosure. Launched in 2018, it embeds encrypted identity into every transaction at the protocol level, enabling accountability while preserving user confidentiality.  The project is backed by industry leaders from Volvo, IKEA, and Credit Suisse, among others, and aims to make blockchain adoption seamless for enterprises. Concordium has secured €52M in funding and partnered with Geely, a global automaker and co-owner of Volvo Cars, Volvo AB, and Daimler.  The newly appointed CEO and Executive Management team have revealed a focused strategic direction to double down on enabling stablecoin issuers, financial institutions, and payment providers to accelerate real-world adoption. With stablecoin settlement volumes projected to reach $300 billion per day by 2025, Concordium delivers a blockchain infrastructure uniquely suited for secure, programmable money solutions.

Concordium

Concordium ($CCD) is trending due to its recent partnership with bitcoin.com, focused on bringing age-verified stablecoin payments to a wide user base. The community is highlighting $CCD's focus on privacy, identity, and trust, drawing comparisons to other privacy projects and anticipating further exchange listings. Some users believe its undervalued status and enterprise-ready blockchain position it for significant growth, especially with growing institutional interest.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASPI is trending as investors discuss the potential revenue boost from producing various isotopes, including those for next-generation SMR reactors. Community members are also excited about the momentum building with recycling tech, UK nuclear regulation progress, Trump family backing, and the upcoming investor event expected to provide more news to bolster the company valuation. The potential QLE spin-off continues to be a central point of discussion.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending as investors anticipate upcoming data presentations, particularly CTX310 at the American Heart Association meeting in November, which some believe could be a major catalyst. Bullish sentiment is fueled by insider buying and a growing consensus that the company is undervalued, with the potential for a significant short squeeze. Community members are closely watching for earnings and pipeline updates, while also speculating on potential acquisitions or partnerships.

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Rezolute Inc

RZLT is trending due to significant call options activity, signaling potential institutional interest and a possible upcoming squeeze, with traders pointing to insider buying and the termination of an 'at-the-money' offering as bullish indicators. The community is focused on the company's Phase 3 sunRIZE trial data expected in December and speculation around a possible acquisition given overlapping management hires with Ultragenyx. Some investors express caution regarding an upcoming investor event so close to pivotal data, while others believe the event signals an imminent M&A deal.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as investors discuss the implications of Michael Weiss's recent stock transfer to family trusts, with some speculating it signals potential buyout negotiations. The community is also analyzing revenue growth and upcoming earnings, while also pointing to the potential impact of subq Briumvi and the company's long-term prospects within the competitive MS market.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

IDYA is trending due to recent clinical data updates and upcoming events, including the potential for accelerated approval of their uveal melanoma treatment.  The community is actively discussing the company's pipeline and potential for label expansion, as well as analyst ratings and price targets. The company's strong cash position and strategic collaborations are also being highlighted as positive factors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Energy And Financials Lead This Week’s Deep-Value Screen $BK $PBR $SBS $SYF $EQNR https://talkmarkets.com/content/us-markets/energy-and-financials-lead-this-weeks-deep-value-screen?post=533499

Energy and Financials once again dominate the deep-value landscape in this week's screen.